Report of HCC developing in a patients receiving biologic therapies. Immunomodulation obtained through biologic agents (not only anti-TNF) recapitulates an accelerated version of the natural history of HBV infection including the development/progression of HCC. All patients undergoing to immunosuppression should be carfefkully checked and treated for hepatatis B.
Hepatocellular carcinoma in a patient treated with efalizumab for psoriasis / Lonardo, A; Nascimbeni, Fabio; Ballestri, Stefano; Mascia, Maria Teresa; Iori, R; Loria, Paola. - In: HEPATOLOGY RESEARCH. - ISSN 1386-6346. - STAMPA. - 42:(2012), pp. 945-945. [10.1111/j.1872-034X.2012.00999.x]